Literature DB >> 30893288

Implementing the Serious Illness Care Program in Primary Care.

Jill A Massmann1, Sara S Revier, Julie Ponto.   

Abstract

Inadequate communication about serious illness care preferences affects patients, families, health care providers, and health care systems. Many patient and system barriers prevent comprehensive serious illness communication. The purpose of this evidence-based practice project was to provide a structure within a primary care clinic to facilitate conversations with seriously ill individuals about their care preferences that (a) was adaptable to clinic workflow, (b) improved providers' perception of the care conversation experience, (c) improved documentation of care preferences, and (d) provided a comfortable and helpful experience. The Johns Hopkins Nursing Evidence-Based Practice model and Serious Illness Care Program were used to address provider and system barriers to conversations about care preferences. Program interventions included training providers and staff; identifying patients at risk for high symptom burden and mortality; integrating system interventions; and evaluating outcomes. Providers completed training, after which a 5-week pilot practice change was conducted. Provider perceptions of conversations after implementation were positive. During the pilot, 3 serious illness care conversations were initiated with additional patients prepared for future conversations using an information sheet and introduction to the conversation.

Entities:  

Year:  2019        PMID: 30893288     DOI: 10.1097/NJH.0000000000000531

Source DB:  PubMed          Journal:  J Hosp Palliat Nurs        ISSN: 1522-2179            Impact factor:   1.918


  2 in total

Review 1.  Patient Identification for Serious Illness Conversations: A Scoping Review.

Authors:  Rebecca Baxter; Erik K Fromme; Anna Sandgren
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

2.  A prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis.

Authors:  Sarah P Huepenbecker; Xiaochen Zhang; Mark A Morgan; Ashley F Haggerty
Journal:  Gynecol Oncol Rep       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.